XTX Topco Ltd Makes New $1.34 Million Investment in Inspire Medical Systems, Inc. (NYSE:INSP)

XTX Topco Ltd acquired a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) in the 2nd quarter, Holdings Channel reports. The fund acquired 9,997 shares of the company’s stock, valued at approximately $1,338,000.

Several other large investors have also modified their holdings of INSP. Seven Eight Capital LP acquired a new stake in Inspire Medical Systems during the 2nd quarter worth $3,098,000. Blair William & Co. IL increased its position in shares of Inspire Medical Systems by 13.1% during the second quarter. Blair William & Co. IL now owns 7,826 shares of the company’s stock worth $1,047,000 after purchasing an additional 905 shares in the last quarter. Amalgamated Bank lifted its holdings in shares of Inspire Medical Systems by 4.1% in the 2nd quarter. Amalgamated Bank now owns 2,005 shares of the company’s stock valued at $268,000 after purchasing an additional 79 shares during the last quarter. Sofinnova Investments Inc. lifted its holdings in shares of Inspire Medical Systems by 23.5% in the 2nd quarter. Sofinnova Investments Inc. now owns 10,000 shares of the company’s stock valued at $1,338,000 after purchasing an additional 1,901 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Inspire Medical Systems by 79.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 109,560 shares of the company’s stock valued at $14,663,000 after purchasing an additional 48,590 shares during the period. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Price Performance

Shares of INSP stock opened at $212.85 on Friday. The business’s fifty day moving average price is $176.48 and its 200 day moving average price is $182.06. The firm has a market capitalization of $6.32 billion, a PE ratio of -387.00 and a beta of 1.33. Inspire Medical Systems, Inc. has a 1-year low of $123.00 and a 1-year high of $257.40.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.46. Inspire Medical Systems had a net margin of 0.85% and a return on equity of 1.03%. The business had revenue of $195.89 million for the quarter, compared to analysts’ expectations of $189.08 million. During the same period in the prior year, the company posted ($0.41) EPS. The business’s revenue for the quarter was up 29.6% on a year-over-year basis. Equities research analysts expect that Inspire Medical Systems, Inc. will post 0.75 earnings per share for the current fiscal year.

Insider Buying and Selling at Inspire Medical Systems

In other news, insider Randy Ban sold 4,861 shares of Inspire Medical Systems stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $188.55, for a total transaction of $916,541.55. Following the completion of the sale, the insider now directly owns 3,056 shares in the company, valued at approximately $576,208.80. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Shawn Mccormick sold 800 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $220.00, for a total value of $176,000.00. Following the sale, the director now directly owns 23,140 shares of the company’s stock, valued at approximately $5,090,800. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Randy Ban sold 4,861 shares of Inspire Medical Systems stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $188.55, for a total transaction of $916,541.55. Following the transaction, the insider now owns 3,056 shares of the company’s stock, valued at approximately $576,208.80. The disclosure for this sale can be found here. Over the last three months, insiders sold 5,692 shares of company stock valued at $1,099,207. Corporate insiders own 4.10% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on INSP. KeyCorp cut their price target on Inspire Medical Systems from $278.00 to $236.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. Leerink Partners upped their price target on shares of Inspire Medical Systems from $167.00 to $197.00 and gave the company a “market perform” rating in a research report on Tuesday, September 10th. Stifel Nicolaus lowered their price objective on shares of Inspire Medical Systems from $210.00 to $170.00 and set a “hold” rating on the stock in a research report on Monday, June 24th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $260.00 target price on shares of Inspire Medical Systems in a report on Wednesday, August 7th. Finally, Bank of America lowered their price target on Inspire Medical Systems from $225.00 to $185.00 and set a “neutral” rating on the stock in a report on Monday, June 3rd. Five analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Moderate Buy” and a consensus target price of $214.85.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.